Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.

@article{Festi2007ClinicalEA,
  title={Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.},
  author={Davide Festi and Marco Montagnani and Francesco Azzaroli and Francesca Lodato and Giuseppe Mazzella and Aldo Roda and Anna Rita di Biase and Enrico Roda and P. O. Simoni and Antonio Colecchia},
  journal={Current clinical pharmacology},
  year={2007},
  volume={2 2},
  pages={155-77}
}
Ursodeoxycholic acid (UDCA), previously used for cholesterol gallstone dissolution, is currently considered the first choice therapy for many forms of cholestatic syndromes. Many mechanisms and sites of action have been proposed for UDCA, but definitive data are still missing regarding the key points of its efficacy and optimal dosage in order to achieve a… CONTINUE READING